Study finds source of tetracycline from bone analysis of Nubians

NewsGuard 100/100 Score

New bone analysis shows ancient Nubians consumed tetracycline, most likely in their beer

A chemical analysis of the bones of ancient Nubians shows that they were regularly consuming tetracycline, most likely in their beer. The finding is the strongest evidence yet that the art of making antibiotics, which officially dates to the discovery of penicillin in 1928, was common practice nearly 2,000 years ago.

The research, led by Emory University anthropologist George Armelagos and medicinal chemist Mark Nelson of Paratek Pharmaceuticals, Inc., is in the current issue of the American Journal of Physical Anthropology.

"We tend to associate drugs that cure diseases with modern medicine," Armelagos says. "But it's becoming increasingly clear that this prehistoric population was using empirical evidence to develop therapeutic agents. I have no doubt that they knew what they were doing."

Armelagos is a bioarcheologist and an expert on prehistoric and ancient diets. In 1980, he discovered what appeared to be traces of tetracycline in human bones from Nubia dated between A.D. 350 and 550, populations that left no written record. The ancient Nubian kingdom was located in present-day Sudan, south of ancient Egypt.

Armelagos and his fellow researchers later tied the source of the antibiotic to the Nubian beer. The grain used to make the fermented gruel contained the soil bacteria streptomyces, which produces tetracycline. A key question was whether only occasional batches of the ancient beer contained tetracycline, which would indicate accidental contamination with the bacteria.

Nelson, a leading expert in tetracycline and other antibiotics, became interested in the project after hearing Armelagos speak at a conference. "I told him to send me some mummy bones, because I had the tools and the expertise to extract the tetracycline," Nelson says. "It's a nasty and dangerous process. I had to dissolve the bones in hydrogen fluoride, the most dangerous acid on the planet."

The results stunned Nelson. "The bones of these ancient people were saturated with tetracycline, showing that they had been taking it for a long time," he says. "I'm convinced that they had the science of fermentation under control and were purposely producing the drug."

Even the tibia and skull belonging to a 4-year-old were full of tetracycline, suggesting that they were giving high doses to the child to try and cure him of illness, Nelson says.

The first of the modern day tetracyclines was discovered in 1948. It was given the name auereomycin, after the Latin word "aerous," which means containing gold. "Streptomyces produce a golden colony of bacteria, and if it was floating on a batch of beer, it must have look pretty impressive to ancient people who revered gold," Nelson theorizes.

The ancient Egyptians and Jordanians used beer to treat gum disease and other ailments, Armelagos says, adding that the complex art of fermenting antibiotics was probably widespread in ancient times, and handed down through generations.

The chemical confirmation of tetracycline in ancient bones is not the end of the story for Armelagos. He remains enthused after more than three decades on the project. "This opens up a whole new area of research," he says. "Now we're going to compare the amount of tetracycline in the bones, and bone formation over time, to determine the dosage that the ancient Nubians were getting."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel tool to predict a person's risk for cardiovascular complications after bone marrow transplant